Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs) EQUITY
$160.44
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AMGN Avg Daily Volume: 3,289,500
Last Update: 05/27/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 0.72%
Open: $0.00
Previous Close: $160.44
52 Week Range: $114.93 - $173.60
Oustanding Shares: 760,323,664
Market Cap: 120,899,065,813
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 2 2
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.13 2.09 2.09
Latest Dividend: 0.79
Latest Dividend Yield: 1.99%
Dividend Ex-Date: 05/12/15
Price Earnings Ratio: 21.46
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
21.46 21.50 26.72
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.72% 38.44% 132.35%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.40 0.29 0.09
Net Income 1.50 0.40 0.12
EPS 0.90 0.67 0.18
Earnings for AMGN:
EBITDA 8.74B
Revenue 20.06B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $2.42 $2.38 $9.58 $10.56
Number of Analysts 11 10 11 12
High Estimate $2.62 $2.52 $9.86 $11.16
Low Estimate $2.32 $2.24 $9.24 $10.24
Prior Year $2.37 $2.30 $8.68 $9.58
Growth Rate (Year over Year) 2.26% 3.48% 10.36% 10.26%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | May 27, 2015 | 12:00 PM EDT

Have it ready in case market turns volatile.

updateAMGN Investor Mtg.

May 14, 2015 | 7:58 AM EDT

AMGN - Amgen Inc Annual Shareholders Meeting - 2PM

updateDeutsche Healthcare Conf.

May 7, 2015 | 6:41 AM EDT

Deutsche Bank Health Care Conference

By

Robert Lang

 | Apr 29, 2015 | 2:00 PM EDT

CSCO has corrected to a stronger support level and may be on the verge of moving higher.

By

Chris Versace and Lenore Hawkins

 | Apr 22, 2015 | 5:00 PM EDT

March quarter earnings take a front seat.

By

James "Rev Shark" DePorre

 | Apr 22, 2015 | 4:44 PM EDT

There's plenty of green on the screen.

By

Robert Lang

 | Apr 22, 2015 | 10:52 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Robert Lang

 | Apr 22, 2015 | 10:00 AM EDT

Gilead's Relative Strength Index slope is very strong.

bullishAmgen estimates, target boosted at Jefferies

Apr 22, 2015 | 7:16 AM EDT

Shares of AMGN now seen reaching $195, according to Jefferies. Company is seeing higher sales and keeping a tight lid on costs. Buy rating.  

By

James "Rev Shark" DePorre

 | Apr 21, 2015 | 4:19 PM EDT

It's totally unremarkable, but there's no major weakness.

Market recovers from yesterday's losses as investors go back into "risk on" mode. Concert ...
We added this name a few weeks back and now it is the talk of the buyout craze. No matter...
Intel (INTC)'s pattern off the March corrective low (29.31) exhibits bullish form, which "...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.